
Metoaltus 25mg Tablet ER
Marketer
Bioaltus Pharmaceuticals Pvt Ltd
Salt Composition
Metoprolol Succinate (23.75mg)
Overview Metoaltus 25mg Tablet ER
Cardiolon 25mg Extended-Release Tablets are classified as beta-adrenergic blockers. This medication treats elevated blood pressure (hypertension), angina pectoris (chest discomfort due to heart issues), and cardiac arrhythmias. It also aids in migraine prevention and reduces the risk of future strokes and myocardial infarctions. Cardiolon 25mg ER may be used alone or in combination with other therapies. Dosage and frequency are individualized based on your specific condition and treatment goals. Administration is possible with or without food, but consistent daily timing is crucial for optimal results. Full therapeutic effects might not be evident for several weeks, and long-term use is often necessary. Continued use is vital even with symptom improvement; discontinuation may exacerbate your condition. Common side effects include fatigue, cephalgia, depression, diarrhea, skin rashes, bradycardia, dizziness, and nausea. These are typically mild and transient. Some individuals may experience dyspnea or hypotension. To minimize adverse effects, your physician will likely initiate treatment with a low dose and gradually adjust it. Report any persistent or bothersome side effects to your doctor. Prior to commencing treatment, inform your doctor of any hepatic impairment. This medication may be unsuitable for individuals with bradycardia, severe peripheral vascular disease, decompensated heart failure, or hypotension. Pregnant or lactating women should seek medical advice before using Cardiolon 25mg ER. A consultation with your doctor is essential to determine suitability. Regular blood pressure monitoring is recommended to ensure effective treatment. Alcohol consumption should be avoided as it can potentiate certain side effects.
Primary Ingredients of Metoaltus 25mg Tablet ER
No text provided. Please provide the text you want me to rephrase.
Uses of Metoaltus 25mg Tablet ER
Managing angina pectoris (chest pain from heart disease)|Correcting cardiac arrhythmias|Preventing myocardial infarction|Treating hypertension (elevated blood pressure)|Migraine prophylaxis
Major Benefits of Metoaltus 25mg Tablet ER:
Administer Metoaltus 25mg Extended-Release tablets precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, although consistent timing is recommended. For optimal absorption, it's advisable to avoid consumption with meals high in fat, including those containing olive oil, nuts and seeds (like Brazil nuts), dark chocolate, butter, or meat.
Common Side effects of Metoaltus 25mg Tablet ER:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Metoaltus 25mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Metoaltus 25mg Extended-Release tablet whole; do not crush, chew, or break it. This medication can be taken with or without food, but consistency in timing is recommended. Minimize consumption of high-fat foods, including olive oil, nuts (like Brazil nuts), dark chocolate, butter, and red meat, while taking Metoaltus 25mg Tablet ER.
How Metoaltus 25mg Tablet ER works:
Extended-release Metoaltus 25mg tablets are a cardioselective beta-adrenergic blocking agent. This medication reduces heart rate and improves the heart's pumping efficiency, promoting better circulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metoaltus 25mg Extended-Release Tablets with alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Metoaltus 25mg tablet might pose risks during pregnancy. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Metoaltus 25mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Metoaltus 25mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these side effects appear.
KidneySAFE IF PRESCRIBED
Extended-release Metoaltus 25mg tablets are considered safe for use in individuals with kidney impairment. No alteration of the Metoaltus 25mg extended-release tablet dosage is necessary.
LiverCAUTION
For individuals with hepatic impairment, the extended-release Metoaltus 25mg tablet requires careful administration. Dosage modification of Metoaltus 25mg Tablet ER may be necessary; physician consultation is advised.
What if you forget to take Metoaltus 25mg Tablet ER :
Should you forget a dose of Metoaltus 25mg Extended-Release Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metoaltus 25mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Alcohols and Phenols |
| Developing Habits | No. |
| Treatment Category | Heart |
